Proenkephalin ANd Creatinine in the Prediction of Cardiac Contrast-Associated Kidney Events
Currently, contrast-induced kidney injury cannot be diagnosed on the day of cardiac catheterization. Recently, proenkephalin (penKid) was introduced as a new glomerular filtration marker. The aim of this study is to investigate whether the change in penKid level allows for early detection of affected patients.
Indication: Contrast-induced Nephropathy
Modality: protein therapy
Target: blood-draw for biomarker analyses
Sponsor: Dr. med. Mahir Karakas
Source URL: ClinicalTrials.gov
Source updated: May 18, 2022
Ingested: May 22, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: blood-draw for biomarker analyses
View original source fields
Condition raw: Contrast-induced Nephropathy, Acute Kidney Injury, Coronary Artery Disease
Condition normalized: Contrast-induced Nephropathy, Acute Kidney Injury, Coronary Artery Disease
Modality raw: protein therapy
Modality normalized: protein therapy
Target raw: blood-draw for biomarker analyses
Target normalized: blood-draw for biomarker analyses